Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of...

Feb 14, 2025 · GLP-1 agonist drugs treat diabetes by balancing blood glucose levels. Here’s our list of GLP-1 agonists, how they work, similarities and differences, and more.

GLP-1 agonists are medications that help lower blood sugar levels and promote weight loss. There are many different types. And they’re just one part of your treatment plan if you have Type 2 diabetes or obesity. Your healthcare provider can help you decide if they’re right for you. What are GLP-1 agonists?

Mar 10, 2025 · This medication is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it can help treat type 2 diabetes by prompting your body to make more insulin and reduce blood sugar...

Aug 6, 2024 · Most of us know that there are injectable GLP-1 drugs for type 2 diabetes and obesity, sold under brand names such as Ozempic and Wegovy. But did you know there are also pill versions of this class of drug—and there might be more on the way?

Popular brands of the GLP-1 receptor agonist semaglutide — including Ozempic and Rybelsus —are approved by the Food and Drug Administration (FDA) for treating diabetes, while Wegovy is FDA-approved for obesity management.

May 6, 2024 · Glucagon-like peptide-1 receptor agonists, often referred to simply as GLP-1s, are a class of medications primarily used to treat type 2 diabetes, though some formulations are also...

Jun 23, 2024 · Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound. Some of the experimental drugs...

Jan 13, 2025 · In 2025, glucagon-like peptide-1 (GLP-1) receptor agonists may gain FDA approval for new uses. Examples include chronic kidney disease and certain types of heart failure and liver disease. New injectable GLP-1s are advancing through clinical trials.

Feb 19, 2025 · Compared to placebo, all of the GLP-1 drugs caused more nausea and vomiting. What is the cost of GLP-1 drugs? The cost of GLP-1 drugs can depend on insurance coverage and manufacturer assistance programs. Below is a list of cash prices for a one-month supply of GLP-1 drugs: Bydureon 2 mg: $510.95; Byetta 10 mcg/0.04 mL: $896.60